A multi-dimensional computational screening strategy for rapid identification of active components from traditional chinese medicine: Validation and application in Liangdi decoction against endometriosis

Ren X, Xueyang Ren, Wanzhu Wang, Wang W, Chen W, W L Chen, Weiyu Chen, Zhang H, Haojia Zhang, Juan Qin, Qin J, Yao J, Jianling Yao, Yu Cao, Cao Y, Ying L, Letian Ying, Yuqing Yang, Yanrong Yang, Yongqi Yang, Yang Y, Wu X, Xinru Wu, Xing J, Jiaqian Xing, Wu L, Lingzi Wu, Qingqing Song, Song Q, Gaimei She, She G
Computational biology and chemistry · 2026 · vol. 124(Pt 1) , pp. 109118 · doi:10.1016/j.compbiolchem.2026.109118 · PMID:42119370 · W7160950591
article OA: closed public-domain-us
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

This study developed and validated a multi-dimensional computational screening strategy integrating target affinity, exposure, and safety to identify kukoamine A, ophiopogonanone E, and verbascoside as promising endometriosis-treating components from Liangdi decoction.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

AIMS: This study aims to develop and validate a Multi-Dimensional Computational Screening (MDCS) strategy to identify bioactive components by jointly considering target affinity, exposure potential, and safety, using Liangdi decoction (LDD) as a case study. METHODOLOGY: Key therapeutic targets for endometriosis were identified by analyzing Gene Expression Omnibus and MalaCards databases. The components in LDD were identified using HPLC-MS/MS combined with feature-based molecular networking. An MDCS strategy integrating molecular docking, VlseKriterijumska Optimizacija I Kompromisno Resenje (VIKOR) multi-criteria decision analysis, and machine learning was developed. Molecular docking was conducted to estimate affinity, and VIKOR multi-criteria decision analysis was applied to generate rankings by simultaneously considering docking performance, content, intestinal absorption, and hepatorenal toxicity. Machine learning was used to identify physicochemical features associated with target-specific binding, providing interpretable rules for component prioritization. Molecular dynamics simulations and surface plasmon resonance experiments were performed to validate. RESULTS: Estrogen receptor, progesterone receptor, and gonadotropin-releasing hormone receptor were identified as major targets relevant to endometriosis. Among 131 characterized components, kukoamine A, ophiopogonanone E, and verbascoside were prioritized as optimal candidates targeting the three receptors, respectively. Machine learning revealed QED, Fsp3, and logD as critical determinants of binding affinity. CONCLUSIONS: This study establishes a structured computational framework for discovering bioactive TCM constituents by integrating efficacy, druggability, and safety considerations, addressing key limitations of docking-based screening and providing a transferable strategy for target-directed herbal research.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal Drugs, Chinese Herbal

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

References (35)

SciLite annotations

organisms 1
varnish tree
chemicals 3
kukoamine a pentalenolactone e verbasoside

Source provenance

europepmc
last seen: 2026-08-01T06:07:04.264727+00:00
openalex
last seen: 2026-08-01T06:00:24.223380+00:00
pubmed
last seen: 2026-08-01T06:02:23.048493+00:00
scilite
last seen: 2026-06-21T06:47:03.627287+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine